Tirzepatide was originally developed to treat Type-2 diabetes but has since become a leading anti-obesity medication. It is a dual agonist of the GLP-1 and GIP receptors — meaning it activates two distinct hormonal pathways to reduce appetite, improve metabolic rate, and support sustained weight loss. For research purposes only. This product is supplied...

KPV is a tripeptide studied for its anti-inflammatory and immune-modulating properties. Used in vitro, it offers research potential in inflammation regulation, gut health, and skin regeneration, making it a valuable tool for immunology studies. For research purposes only. This product is supplied exclusively for scientific laboratory research and...